News
Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...
Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.
2d
MoneyWeek on MSNCash in on the biotech boom with three promising European picksAilsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...
Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...
AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...
ITeos Therapeutics is throwing in the towel. | iTeos Therapeutics is throwing in the towel. Two weeks after axing its ...
This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...
If these times have anything to say about it, the next Microsoft is coming from the biotech sector. Investors are moving in looking for profits, even putting companies without products on the map.
Pharmaceutical giant Eli Lilly is the world's most valuable drug company. A chemist and veteran of the Union Army founded the company in 1876, and it later became the first to mass-produce insulin ...
Two groundbreaking biotechnology advances are fundamentally altering human health and food production in 2025, moving from ...
Since Bernard Ravina's medical training in neurology in the '90s, there have been few new therapies that treat a movement ...
1 Day BNR 1.23% DJIA 1.78% Russell 2K 2.48% Health Care/Life Sciences -0.87% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results